Werner Baumann, Bayer CEO (Malte Ossowski/SVEN SIMON/picture-alliance/dpa/AP Images)

Bay­er rush­es sup­port to Ukraine staff, help­ing with cash and hous­ing as Rus­sians at­tack ma­jor cities

Bay­er ex­ecs cov­ered all the ma­jor pock­et­book is­sues you’d ex­pect in its Q4 call with an­a­lysts to­day. But clear­ly the in­va­sion of Ukraine — and the widen­ing glob­al cri­sis that has de­vel­oped as bombs fall on a civil­ian pop­u­la­tion — has cap­tured their at­ten­tion. And it be­came a cen­tral fo­cus in their pre­sen­ta­tion to­day.

“Be­fore we go in­to the busi­ness per­for­mance,” Bay­er CEO Wern­er Bau­mann said, “let me start with what is cer­tain­ly top of mind for all of us. With the Russ­ian in­va­sion of Ukraine, the geopo­lit­i­cal or­der is shak­en and we are deeply shocked and con­cerned with what is hap­pen­ing to the Ukrain­ian peo­ple. This war is no less than a threat to our free­dom and democ­ra­cy and we at Bay­er con­demn in the most vig­or­ous way, this Russ­ian at­tack.”

Endpoints Premium

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.